Antibiotic Research UK Annual Lecture 2021

Professor Kevin Outterson will give the ANTRUK 2021 Annual Lecture

We’re delighted to announce the title of this year’s ANTRUK Annual Lecture: ‘Smarter ways to buy antibacterials’ given by Professor Kevin Outterson. Professor Outterson is the Executive Director of CARB-X.

Developing new treatments against antibiotic resistant bacteria is of key importance if we are to see a world where no one dies from a drug-resistant infection. These new treatments can only be developed if there is sufficient funding available to support blue skies research. CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is one of the prime funders of early stage drug development.

With up to US$480 million to invest in 2016-22, CARB-X funds the best science from around the world. The CARB-X portfolio is also the world’s largest early development pipeline of new antibiotics, vaccines, and rapid diagnostics. CARB-X develop other products to prevent, diagnose and treat life-threatening bacterial infections as well.

2021 ANTRUK Annual Lecture

Professor Outterson’s lecture, ‘Smarter ways to buy antibacterials’, will take place in the afternoon of Thursday 21 October 2021. We’re hosting the event at the Royal College of Pathologists, 6 Alie Street, London E1 8QT. The event will be face to face but we are hoping to have a virtual option for those outside the UK.

Abstract: Antibacterial effectiveness is a global public good, but is being eroded by resistance and broken business models. Professor Outterson will outline the problems we face from drug-resistant bacteria. Importantly, he will outline clear solutions, focusing on changing the way health systems and governments buy antibacterials. The UK leads the world on this issue.

Tickets for the event can be obtained from Eventbrite by clicking HERE. Media enquiries should be sent to media@antibioticresearch.org.uk

You can also find out more about supporting our life saving work HERE. Antibiotic Research UK is the world’s first charity dedicated to overcoming bacterial antibiotic resistance. Resistance is a global health disaster that is already killing 700,000 people a year. Without intervention, it will become a global health crisis predicted to cause 10 million deaths per year by 2050.